D
Context Therapeutics Inc. CNTX
$0.8595 -$0.0134-1.54% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -92.85% -36.93% 80.85% -674.45% 38.53%
Total Depreciation and Amortization 0.00% 41.38% 3.57% 7.69% 0.00%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 30.06% 24.35% -98.28% 9,441.08% -34.58%
Change in Net Operating Assets 431.97% 57.51% -435.15% 143.16% -34.80%
Cash from Operations -16.04% -2.48% -153.80% 42.39% 23.04%
Capital Expenditure 100.00% -- 100.00% -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- 100.00% -- --
Cash from Investing 100.00% -- 100.00% -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 100.00% -- -- -- --
Cash from Financing 100.00% -100.11% 32,689.69% -100.05% --
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -14.92% -152.74% 157.53% -118.30% 2,197.13%